Profil
Tausif Butt currently works at Navigator Medicines, Inc., as Chief Executive Officer from 2025.
Mr. Butt also formerly worked at AstraZeneca PLC, as Senior Vice President-Latin America from 2019 to 2021, ChemoCentryx, Inc., as Chief Operating Officer & Executive Vice President from 2021 to 2022, and Idorsia Pharmaceuticals US, Inc., as President & General Manager.
Mr. Butt received his graduate degree from Imperial College London and undergraduate degree from the University of Brighton.
Aktive Positionen von Tausif Butt
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Tausif Butt
| Unternehmen | Position | Ende |
|---|---|---|
| CHEMOCENTRYX, INC. | Geschäftsführer | 20.10.2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2021 |
Idorsia Pharmaceuticals US, Inc. | Präsident | - |
Ausbildung von Tausif Butt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Brighton
University of Brighton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idorsia Pharmaceuticals US, Inc. | Health Technology |
















